334 related articles for article (PubMed ID: 22878095)
21. Lipids: a key for hepatitis C virus entry and a potential target for antiviral strategies.
Blaising J; Pécheur EI
Biochimie; 2013 Jan; 95(1):96-102. PubMed ID: 22884392
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
[TBL] [Abstract][Full Text] [Related]
23. Regulated Entry of Hepatitis C Virus into Hepatocytes.
Miao Z; Xie Z; Miao J; Ran J; Feng Y; Xia X
Viruses; 2017 May; 9(5):. PubMed ID: 28486435
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus envelope glycoprotein signatures are associated with treatment failure and modulation of viral entry and neutralization.
Schvoerer E; Moenne-Loccoz R; Murray JM; Velay A; Turek M; Fofana I; Fafi-Kremer S; Erba AC; Habersetzer F; Doffoël M; Gut JP; Donlin MJ; Tavis JE; Zeisel MB; Stoll-Keller F; Baumert TF
J Infect Dis; 2013 Apr; 207(8):1306-15. PubMed ID: 23335805
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus is restricted at both entry and replication in mouse hepatocytes.
Park IW; Ndjomou J; Fan Y; Henao-Mejia J; He JJ
Biochem Biophys Res Commun; 2009 Sep; 387(3):489-93. PubMed ID: 19619513
[TBL] [Abstract][Full Text] [Related]
26. A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.
Liu R; Tewari M; Kong R; Zhang R; Ingravallo P; Ralston R
Antiviral Res; 2010 May; 86(2):172-9. PubMed ID: 20156485
[TBL] [Abstract][Full Text] [Related]
27. DNA methyltransferases 1 and 3B are required for hepatitis C virus infection in cell culture.
Chen C; Pan D; Deng AM; Huang F; Sun BL; Yang RG
Virology; 2013 Jun; 441(1):57-65. PubMed ID: 23545144
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse model.
Fukasawa M; Nagase S; Shirasago Y; Iida M; Yamashita M; Endo K; Yagi K; Suzuki T; Wakita T; Hanada K; Kuniyasu H; Kondoh M
J Virol; 2015 May; 89(9):4866-79. PubMed ID: 25673725
[TBL] [Abstract][Full Text] [Related]
29. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticosteroids increase cell entry by hepatitis C virus.
Ciesek S; Steinmann E; Iken M; Ott M; Helfritz FA; Wappler I; Manns MP; Wedemeyer H; Pietschmann T
Gastroenterology; 2010 May; 138(5):1875-84. PubMed ID: 20152835
[TBL] [Abstract][Full Text] [Related]
31. Ficolin-2 inhibits hepatitis C virus infection, whereas apolipoprotein E3 mediates viral immune escape.
Zhao Y; Ren Y; Zhang X; Zhao P; Tao W; Zhong J; Li Q; Zhang XL
J Immunol; 2014 Jul; 193(2):783-96. PubMed ID: 24928988
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
33. Cell entry of hepatitis C virus.
Bartosch B; Cosset FL
Virology; 2006 Apr; 348(1):1-12. PubMed ID: 16455127
[TBL] [Abstract][Full Text] [Related]
34. EWI-2wint--a host cell factor inhibiting hepatitis C virus entry.
Schuster C; Baumert TF
J Hepatol; 2009 Jan; 50(1):222-4. PubMed ID: 19019480
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus cell entry: role of lipoproteins and cellular receptors.
Burlone ME; Budkowska A
J Gen Virol; 2009 May; 90(Pt 5):1055-1070. PubMed ID: 19264629
[TBL] [Abstract][Full Text] [Related]
36. Expanding the Host Range of Hepatitis C Virus through Viral Adaptation.
von Schaewen M; Dorner M; Hueging K; Foquet L; Gerges S; Hrebikova G; Heller B; Bitzegeio J; Doerrbecker J; Horwitz JA; Gerold G; Suerbaum S; Rice CM; Meuleman P; Pietschmann T; Ploss A
mBio; 2016 Nov; 7(6):. PubMed ID: 27834208
[TBL] [Abstract][Full Text] [Related]
37. Functional Analysis of Hepatitis C Virus (HCV) Envelope Protein E1 Using a
Tong Y; Chi X; Yang W; Zhong J
J Virol; 2017 Apr; 91(7):. PubMed ID: 28100619
[TBL] [Abstract][Full Text] [Related]
38. Hepatocytes that express variants of cyclophilin A are resistant to HCV infection and replication.
von Hahn T; Schiene-Fischer C; Van ND; Pfaender S; Karavul B; Steinmann E; Potthoff A; Strassburg C; Hamdi N; Abdelaziz AI; Sarrazin C; Müller T; Berg T; Trépo E; Wedemeyer H; Manns MP; Pietschmann T; Ciesek S
Gastroenterology; 2012 Aug; 143(2):439-47.e1. PubMed ID: 22580540
[TBL] [Abstract][Full Text] [Related]
39. The Arg719 residue at the C-terminal end of the stem region in hepatitis C virus JFH-1 E2 glycoprotein promotes viral infection.
Qin ZL; Ju HP; Wang WB; Ren H; Guan M; Zhao P; Qi ZT
Virus Res; 2013 Mar; 172(1-2):1-8. PubMed ID: 23201584
[TBL] [Abstract][Full Text] [Related]
40. Scavenger receptor class B member 1 (SCARB1) variants modulate hepatitis C virus replication cycle and viral load.
Westhaus S; Deest M; Nguyen ATX; Stanke F; Heckl D; Costa R; Schambach A; Manns MP; Berg T; Vondran FWR; Sarrazin C; Ciesek S; von Hahn T
J Hepatol; 2017 Aug; 67(2):237-245. PubMed ID: 28363797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
